Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2022826859
Up to date per 03.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2022826859
Title / Product Name
VERWENDUNG VON MARIBAVIR ZUR BEHANDLUNG VON CYTOMEGALOVIRUS INFEKTION UND BEHANDLUNGSSCHEMATA DAVON
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2022826859
EP Publication Number
4433065
E-Number
1895775
Language
EN
PCT Number
US22050341
Publication Date
25.09.2024 A
11.03.2026 B1
Registration Date
11.03.2026
AT Publication Date
15.04.2026
Application Date
18.11.2022
Registration Number
-
Priorities
19.11.2021
US
202163281206 P
IPC
A61K 31/7056 20060101AFI20230526BHEP
Maximum Duration of Protection
18.11.2042
Owner
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome Chuo-ku
Osaka-shi, Osaka 541-0045
JP
Representative
No representatives present
Inventor
SONG, Heng
Lexington, MA 02421
US
SUN, Kefeng
Lexington, MA 02421
US
CROUTHAMEL, Matthew
Lexington, MA 02421
US
CHEN, Grace
Lexington, MA 02421
US
ZHU, Andy Z.X.
Lexington, MA 02421
US
MICHON, Ingrid Nicolle
Princeton, NJ 08540
US
BURT, Howard James
Princeton, NJ 08540
US
BARTER, Zoe Elizabeth
Princeton, NJ 08540
US
NEUHOFF, Sibylle
Princeton, NJ 08540
US
Information about Fees
Click here to load the fees